[A14-45] Addendum to Commission A14-22 (Umeclidinium/vilanterol)
Last updated 08.01.2015
Project no.:
A14-45
Commission:
Commission awarded on 02.12.2014 by the Federal Joint Committee (G-BA).
Report type:
Addendum
Status:
Commission completed
Department/Division:
Drug Assessment
Application field:
Airways and respiratory system
Note:
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.
| Project no. | Title | Status |
|---|---|---|
| A14-22 | Umeclidinium/vilanterol - Benefit assessment according to §35a Social Code Book V (dossier assessment) | Commission completed |
Federal Joint Committee (G-BA)
2015-01-08 A G-BA decision was published.